Browsing by Author Mamo, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 69 of 69
Issue DateTitleAuthor(s)
2008Adjunctive versus monotherapeutic treatment for schizophrenia : addressing antipsychotic side effectsHazra, Monica; Mamo, David; Remington, Gary
2007Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D 2 receptors : a PET study in schizophreniaMizrahi, Romina; Rusjan, Pablo; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David; Zipursky, Robert B.; Kapur, Shitij
2013Alzheimer's disease research group (ADRG)Scerri, Charles; Ferry, Peter; Scerri, Anthony; Farrugia Bonello, Rosette; Zahra, Anthony; Mamo, David
2010Analysis of antipsychotic dose reductionUchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Mamo, David
2008The antipsychotic potential of l-stepholidine : a naturally occurring dopamine receptor D1 agonist and D2 antagonistNatesan, Sridhar; Reckless, Greg E.; Barlow, Karen B. L.; Odontiadis, John; Nobrega, Jose N.; Baker, Glen B.; George, Susan R.; Mamo, David; Kapur, Shitij
2010Are antipsychotic prescribing patterns different in older and younger adults? : a survey of 1357 psychiatric inpatients in TorontoSproule, Beth A.; Lake, Jennifer; Mamo, David; Uchida, Hiroyuki; Mulsant, Benoit H.
2009Benzodiazepine and antidepressant use in elderly patients with anxiety disorders : a survey of 796 outpatients in JapanUchida, Hiroyuki; Suzuki, Takefumi; Mamo, David; Mulsant, Benoit H.; Kikuchi, Toshiaki; Takeuchi, Hiroyoshi; Tomita, Masayuki; Watanabe, Koichiro; Yagi, Gohei; Kashima, Haruo
2008Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C] raclopride in healthy humansGraff-Guerrero, Ariel; Willeit, Matthaeus; Ginovart, Nathalie; Mamo, David; Mizrahi, Romina; Rusjan, Pablo; Vitcu, Irina; Seeman, Philip; Wilson, Alan A.; Kapur, Shitij
2012Cholinergic pathways and cognition in patients with schizophrenia : a pilot studyRajji, Tarek K.; Chow, Tiffany W.; Voineskos, Aristotle N.; Links, Kira A.; Miranda, Dielle; Mamo, David; Ismail, Zahinoor; Pollock, Bruce G.; Mulsant, Benoit H.
2010Clozapine and global cognition in schizophreniaRajji, Tarek K.; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo, David; Remington, Gary; Pollock, Bruce G.; Mulsant, Benoit H.
2009Clozapine exposure and the impact of smoking and gender : a population pharmacokinetic studyNg, Wenzie; Uchida, Hiroyuki; Ismail, Zahinoor; Mamo, David; Rajji, Tarek K.; Remington, Gary; Sproule, Beth A.; Pollock, Bruce G.; Mulsant, Benoit H.; Bies, Robert R.
2010Complementary and alternative medicine in psychotic disordersHazra, Monica; Noh, Samuel; Boon, Heather; Taylor, Andree; Moss, Karen; Mamo, David
2009D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaUchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David
2008D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography : an open-label study in patients with schizophreniaMamo, David; Kapur, Shitij; Keshavan, Matcheri; Laruelle, Marc; Taylor, Cindy C.; Kothare, Prajakti A.; Barsoum, Penny; McDonnell, David
2012Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendationSuzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David
2012Delineating the functional neuroanatomy of illness denial or anosognosia in schizophreniaGerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh
2007Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET studyMamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij
2010Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late lifeTing, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.
2015Dopamine D 2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia : a [11 C]-raclopride PET studyNakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Wilson, Alan A.; Houle, Sylvain; Graff-Guerrero, Ariel
2015Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trialNakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel
2012Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE dataSakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2012Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional studyMizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2013Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET studySuzuki, Takefumi; Graff-Guerrero, Ariel; Uchida, Hiroyuki; Remington, Gary; Caravaggio, Fernando; Borlido, Carol; Pollock, Bruce G.; Mulsant, Benoit H.; Deluca, Vincenzo; Ismail, Zahinoor; Mamo, David
2009Dosing of antipsychotics in schizophrenia across the life-spectrumUchida, Hiroyuki; Mamo, David
2004Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosineMamo, David; Remington, Gary; Nobrega, Jose; Hussey, Doug; Chirakal, Raman; Wilson, Alan A.; Baker, Glen; Houle, Sylvain; Kapur, Shitij
2002The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disordersMamo, David; Sweet, Robert A.; Roy Chengappa, Kadiamada N.; Reddy, Ravinder R.; Jeste, Dilip V.
2011Effects of aging on 5‐HT2AR binding : a HRRT PET study with and without partial volume correctionsUchida, Hiroyuki; Chow, Tiffany W.; Mamo, David; Kapur, Shitij; Mulsant, Benoit H.; Houle, Sylvain; Pollock, Bruce G.; Graff-Guerrero, Ariel
2004EMD 281014, a specific and potent 5HT2 antagonist in humans : a dose-finding PET studyMamo, David; Sedman, Ewen; Tillner, Joachim; Sellers, Edward M.; Romach, Myroslava K.; Kapur, Shitij
2013Estimated dopamine D2 receptor occupancy and remission in schizophrenia : analysis of the CATIE dataMoriguchi, Sho; Bies, Robert R.; Remington, Gary; Suzuki, Takefumi; Mamo, David; Watanabe, Koichiro; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2014Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [11C]-(+)-PHNOCaravaggio, Fernando; Nakajima, Shinichiro; Borlido, Carol; Remington, Gary; Gerretsen, Philip; Wilson, Alan; Houle, Sylvain; Menon, Mahesh; Mamo, David; Graff-Guerrero, Ariel
2016Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brainCaravaggio, Fernando; Kegeles, Lawrence S.; Wilson, Alan A.; Remington, Gary; Borlido, Carol; Mamo, David; Graff-Guerrero, Ariel
2011Exploring the neural correlates of delusions of referenceMenon, Mahesh; Schmitz, Taylor W.; Anderson, Adam K.; Graff, Ariel; Korostil, Michele; Mamo, David; Gerretsen, Philip; Addington, Jean; Remington, Gary; Kapur, Shitij
2013Frontotemporoparietal asymmetry and lack of illness awareness in schizophreniaGerretsen, Philip; Chakravarty, M. Mallar; Mamo, David; Menon, Mahesh; Pollock, Bruce G.; Rajji, Tarek K.; Graff-Guerrero, Ariel
2006High-dose quetiapine and photopsiaHazra, Monica; Culo, Sandi; Mamo, David
2011Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosisFuente-Sandoval, Camilo de la; Leon-Ortiz, Pablo; Favila, Rafael; Stephano, Sylvana; Mamo, David; Ramirez-Bermudez, Jesus; Graff-Guerrero, Ariel
2013Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia : analysis of the CATIE dataTsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel; Mimura, Masaru; Uchida, Hiroyuki
2015Illness denial in schizophrenia spectrum disorders : a function of left hemisphere dominanceGerretsen, Philip; Menon, Mahesh; Chakravarty, M. Mallar; Lerch, Jason P.; Mamo, David; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel
2011Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophreniaHazra, Monica; Uchida, Hiroyuki; Sproule, Beth A.; Remington, Gary; Suzuki, Takefumi; Mamo, David
2014Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders : resting state functional connectivityGerretsen, Philip; Menon, Mahesh; Mamo, David; Fervaha, Gagan; Remington, Gary; Pollock, Bruce G.; Graff-Guerrero, Ariel
2009An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18 F] FP-TZTPvan Oosten, Erik M.; Wilson, Alan A.; Stephenson, Karin A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Yudin, Andrei K.; Houle, Sylvain; Vasdev, Neil
2008The inclusion of intellectually and/or physically challenged pupil during the physical education lesson : a case studyMamo, David
2009The intersection of pharmacology, imaging, and genetics in the development of personalized medicineGerretsen, Philip; Muller, Daniel J.; Tiwari, Arun; Mamo, David; Pollock, Bruce G.
2010Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F] setoperone PET studyGerretsen, Philip; Graff-Guerrero, Ariel; Menon, Mahesh; Pollock, Bruce G.; Kapur, Shitij; Vasdev, Neil; Houle, Sylvain; Mamo, David
2015Lack of age-dependent decrease in dopamine D3 receptor availability : a [11C]-(+)-PHNO and [11C]-raclopride positron emission tomography studyNakajima, Shinichiro; Caravaggio, Fernando; Boileau, Isabelle; Chung, Jun Ku; Plitman, Eric; Gerretsen, Philip; Wilson, Alan A.; Houle, Sylvain; Mamo, David; Graff-Guerrero, Ariel
2016Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia : a positron emission tomography dopamine D2/3 receptor occupancy studyFervaha, Gagan; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Pollock, Bruce G.; Nakajima, Shinichiro; Gerretsen, Philip; Rajji, Tarek K.; Mar, Wanna; Iwata, Yusuke; Plitman, Eric; Chung, Jun Ku; Remington, Gary; Graff-Guerrero, Ariel
2017‘Let me win’ : narrative of an intellectually disabled person participating in competitive sportMamo, David
2009Long-term stability of measuring D 2 receptors in schizophrenia patients treated with antipsychoticsUchida, Hiroyuki; Graff-Guerrero, Ariel; Mulsant, Benoit H.; Pollock, Bruce G.; Mamo, David
2009Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia : meta-analysisUchida, Hiroyuki; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Arenovich, Tamara; Mamo, David
2011Management of schizophrenia in late life with antipsychotic medicationsSuzuki, Takefumi; Remington, Gary; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mamo, David
2007Managing suicidality in schizophreniaMamo, David
2011Neurobiology of delusions in Alzheimer’s diseaseIsmail, Zahinoor; Nguyen, Minh-Quan; Fischer, Corinne E.; Schweizer, Tom A.; Mulsant, Benoit H.; Mamo, David
2006A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidoneRemington, Gary; Mamo, David; Labelle, Alain; Reiss, Jeffrey; Shammi, Chekkera M.; Mannaert, Erik; Mann, Steve; Kapur, Shitij
2004A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidoneMamo, David; Kapur, Shitij; Shammi, Chekkera M.; Papatheodorou, George; Mann, Steve; Therrien, Francois; Remington, Gary
2009Predicting age‐specific dosing of antipsychoticsUchida, Hiroyuki; Pollock, Bruce G.; Bies, Robert R.; Mamo, David
2012Predicting hospital length of stay for geriatric patients with mood disordersIsmail, Zahinoor; Arenovich, Tamara; Grieve, Charlotte; Willett, Peggie; Sajeev, Gautam; Mamo, David; MacQueen, Glenda M.; Mulsant, Benoit H.
2012Predicting plasma concentration of risperidone associated with dosage change : a population pharmacokinetic studyUchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Suzuki, Takefumi; Tsunoda, Kenichi; Watanabe, Koichiro; Mimura, Masaru; Bies, Robert R.
2015Predicting plasma olanzapine concentration following a change in dosage : a population pharmacokinetic studyTsuboi, Takashi; Bies, Robert R.; Suzuki, Takefumi; Takeuchi, Hiroyoshi; Nakajima, Shinichiro; Graff-Guerrero, Ariel; Mamo, David; Caravaggio, Fernando; Plitman, Eric; Mimura, Masaru; Pollock, Bruce G.; Uchida, Hiroyuki
2007Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detectionOdontiadis, John; MacKenzie, Erin M.; Natesan, Sridhar; Mamo, David; Kapur, Shitij; Baker, Glen B.
2009The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychoticsMizrahi, Romina; Mamo, David; Rusjan, Pablo; Graff, Ariel; Houle, Sylvain; Kapur, Shitij
2010Sensitivity to antipsychotic drugs in older adultsLeon, Chloe; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Rajji, Tarek K.; Mamo, David
2007Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response - a double-blind PET study in schizophreniaAgid, Ofer; Mamo, David; Ginovart, Nathalie; Vitcu, Irina; Wilson, Alan A.; Zipursky, Robert B.; Kapur, Shitij
2009Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in JapanUchida, Hiroyuki; Suzuki, Takefumi; Mamo, David; Mulsant, Benoit H.; Tsunoda, Kenichi; Takeuchi, Hiroyoshi; Kikuchi, Toshiaki; Nakajima, Shinichiro; Nomura, Kensuke; Tomita, Masayuki; Watanabe, Koichiro; Kashima, Haruo
2009Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT 2A) receptors in older, healthy adultsChow, Tiffany W.; Mamo, David; Uchida, Hiroyuki; Graff- Guerrero, Ariel; Houle, Sylvain; Smith, Gwenn S.; Pollock, Bruce G.; Mulsant, Benoit H.
2011Time course of improvement with antipsychotic medication in treatment-resistant schizophreniaSuzuki, Takefumi; Remington, Gary; Arenovich, Tamara; Uchida, Hiroyuki; Agid, Ofer; Graff-Guerrero, Ariel; Mamo, David
2010Towards the development of new subtype-specific muscarinic receptor radiopharmaceuticals-radiosynthesis and ex vivo biodistribution of [18F] 3-(4-(2-(2-(2-fluoroethoxy) ethoxy) ethylthio)-1, 2, 5-thiadiazol-3-yl)-1-methyl-1, 2, 5, 6-tetrahydropyridinevan Oosten, Erik M.; Wilson, Alan A.; Mamo, David; Pollock, Bruce G.; Mulsant, Benoit H.; Houle, Sylvain; Vasdev, Neil
2011Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia : a case report and systematic literature reviewGerretsen, Philip; Diaz, Pablo; Mamo, David; Kavanagh, Doug; Menon, Mahesh; Pollock, Bruce G.; Graff-Guerrero, Ariel
2011Treatment resistant schizophrenia and response to antipsychotics : a reviewSuzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Rajji, Tarek K.; Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mamo, David
2014The VAGUS insight into psychosis scale-self-report and clinician-rated versionsGerretsen, Philip; Remington, Gary; Borlido, Carol; Quilty, Lena; Hassan, Sabrina; Polsinelli, Gina; Teo, Celine; Mar, Wanna; Simon, Regina; Menon, Mahesh; Pothier, David D.; Nakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Rajji, Tarek K.; Mulsant, Benoit H.; Deluca, Vincenzo; Ganguli, Rohan; Pollock, Bruce G.; Graff-Guerrero, Ariel
2017Vestibular stimulation improves insight into illness in schizophrenia spectrum disordersGerretsen, Philip; Pothier, David D.; Falls, Carolyn; Armstrong, Maxine; Balakumar, Thushanthi; Uchida, Hiroyuki; Mamo, David; Pollock, Bruce G.; Graff-Guerrero, Ariel